Centene Co. (NYSE:CNC) Shares Bought by Lincluden Management Ltd.

Lincluden Management Ltd. increased its stake in shares of Centene Co. (NYSE:CNC) by 1.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 84,590 shares of the company’s stock after buying an additional 902 shares during the quarter. Lincluden Management Ltd.’s holdings in Centene were worth $6,368,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Park Place Capital Corp increased its holdings in shares of Centene by 1,190.0% in the third quarter. Park Place Capital Corp now owns 387 shares of the company’s stock valued at $29,000 after purchasing an additional 357 shares during the period. WR Wealth Planners LLC raised its position in Centene by 41.4% during the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock worth $31,000 after buying an additional 137 shares during the last quarter. Chris Bulman Inc acquired a new stake in shares of Centene in the 2nd quarter worth $33,000. Riverview Trust Co increased its stake in shares of Centene by 154.6% during the second quarter. Riverview Trust Co now owns 527 shares of the company’s stock worth $35,000 after acquiring an additional 320 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. purchased a new position in Centene during the second quarter worth about $36,000. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Trading Up 0.8 %

Shares of CNC stock opened at $62.26 on Friday. Centene Co. has a twelve month low of $59.77 and a twelve month high of $81.42. The company has a market capitalization of $32.75 billion, a price-to-earnings ratio of 10.81, a PEG ratio of 0.85 and a beta of 0.48. The firm has a 50-day moving average price of $71.55 and a 200 day moving average price of $72.02. The company has a current ratio of 1.10, a quick ratio of 1.17 and a debt-to-equity ratio of 0.64.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CNC. StockNews.com downgraded Centene from a “strong-buy” rating to a “buy” rating in a research note on Monday. Cantor Fitzgerald reissued an “overweight” rating and issued a $90.00 target price on shares of Centene in a report on Tuesday, October 1st. Sanford C. Bernstein cut their price target on shares of Centene from $96.00 to $88.00 and set an “outperform” rating for the company in a report on Wednesday. Jefferies Financial Group lowered shares of Centene from a “buy” rating to a “hold” rating and lowered their target price for the stock from $83.00 to $69.00 in a research report on Wednesday, July 24th. Finally, Wells Fargo & Company decreased their price target on Centene from $93.00 to $91.00 and set an “overweight” rating on the stock in a research note on Friday, September 13th. Seven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $84.00.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.